Page 798 - TNFlipTest

N56 Neurology References Toronto Notes 2019
Headache
Mulleners WM, McCrory DC, Linde M. Antiepileptics in migraine prophylaxis: an updated Cochrane review. Cephalalgia 2015;135: 51-62.
Detsky ME, McDonald DR, Baerlocher MO, et al. Does this patient with headache have a migraine or need neuroimaging? JAMA 2006;296:1274-1283.
Francis GJ, Becker WJ, Pringsheim TM. Acute and preventive pharmacologic treatment of cluster headache. Neurology 2010;75:463-473.
Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia 2004;24(S1):9-160. Oldman AD, Smith LA, McQuay HJ, et al. Pharmacological treatments for acute migraine: quantitative systematic review. Pain 2002;97:247-257.
Movement Disorders
Bayard M, Avonda T, Wadzinski J. Restless legs syndrome. Am Fam Physician 2008;78:235-40.
Centers for Disease Control and Prevention (CDC). Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep 2004;53(RR-4):1-33. England JD, Gronseth G, Franklin G, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Neurology 2009;72:185-192. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
Stowe RL, Ives NJ, Clarke CE, et al. Dopamine agonist therapy in early Parkinson’s disease. Cochrane DB Syst Rev 2008:CD006564.
Walkup JT, Ferrao Y, Leckman JF, et al. Tic disorders: some key issues for DSM-V. Depress Anxiety 2010:600-610.
Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015 Oct;30(12):1591-601.
Multiple Sclerosis
Ambati BK, Smith WT, Azer-Bentsianov MT. Residents’ manual of medicine. Hamilton: BC Decker, 2001. 211-213.
Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. NEJM 2012;366:1870-1880.
Carpenter CCJ, Griggs RC, Loscalzo J (editors). Cecil essentials of medicine, 5th ed. Philadelphia: WB Saunders, 2001. 973-976.
Clerico M, Faggiano F, Palace J, et al. Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane DB Syst Rev 2009:CD005278. Ferri FF. Practical guide to the care of the medical patient. St. Louis: Mosby, 2001. 654-656.
La Mantia L, Tramacere I, Firwana B, et al. Fingolimod for relapsing-remitting multiple sclerosis. Cochrane Database of Systematic Reviews 2016; CD009371.
Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. NEJM 2000;343:938-952.
Olek MJ (editor). Multiple sclerosis: etiology, diagnosis, and new treatment strategies. New Jersey: Humana Press, 2005. 36-40, 57, 131, 222-223.
Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005;58:840-846.
Samuels MA, Feske SK (editors). Office practice of neurology, 2nd ed. Philadelphia: Elsevier Science, 2003. 410-411.
The TRANSFORMS Study Group. Oral fingolimod or intramuscular interferon for relapsing MS. NEJM 2010;362:402-415.
Vosoughi R, Freedman MS. Therapy of MS. Clin Neurol Neurosurg 2010;112:365-385.
Neurocognitive Disorders (Dementia)
Feldman HH, Jacova C, Robillard A, et al. Diagnosis and treatment of dementia: diagnosis. CMAJ 2008;178:825-836.
Josephs KA, Ahlskog JE, Parisi JE, et al. Rapidly progressive neurodegenerative dementias. Arch Neurol 2009;66:201-207.
McKeith IG, Dickson DW, Lowe J, et al. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005;65:1863-1872.
Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
Patterson C, Feightner JW, Garcia A, et al. Diagnosis and treatment of dementia: risk assessment and primary prevention of Alzheimer disease. CMAJ 2008;178:548-556.
Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134:2456-2477.
Rolinski M, Fox C, Maidment I, et al. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease. Cochrane DB Syst Rev 2012:CD006504. Vigen CL, Mack WJ, Keefe RS, et al. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer’s disease: outcomes from CATIE-AD. Am J Psychiatry 2011;168:831-839.
Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-815.
Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009;132:2659-2668.
Pain
Chen N, Li Q, Zhang Y, et al. Vaccination for preventing postherpetic neuralgia. Cochrane DB Syst Rev 2011:CD007795.
Coen PG, Scott F, Leedham-Green M, et al. Eur J Pain 2006;10:695-700.
Marcus D. Chronic pain - a primary guide to practical management. New Jersey: Humana Press, 2005. 111-128.
Salinas RA, Alvarez G, Daly F, et al. Corticosteroids for Bell’s palsy (idiopathic facial paralysis). Cochrane DB Syst Rev 2010:CD001942. Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Phys 2010;56:514-517.
Spinal Cord Syndrome
Wagner R, Jagoda A. Neurologic emergencies: spinal cord syndromes. Emerg Med Clinic N Am 1997;15:699-711.
Stroke
Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and Aspirin® versus Aspirin® alone for the prevention of atherothrombotic events. NEJM 2006;354:1706-1717.
Brott TG, Howard G, Roubin GS, et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. NEJM 2016;374:1021-1031.
Bruins Slot KM, Berge E. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane DB Syst Rev. 2014;8:CD008980. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus Aspirin® in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. NEJM 2009;361:1139-1151.
Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin® and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004;364:331-337.
Frontera W, Silver J. Essentials of physical medicine and rehabilitation. Philadelphia: Hanley and Belfus, 2002. 778-782.
Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870.
Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369:283-292.
Lindsay K, Bone I. Neurology and neurosurgery illustrated. Philadelphia: Churchill Livingstone, 2003. 244.
Mullins ME, Lev MH, Scheillingerhout D, et al. Intracranial hemorrhage complicating acute stroke: how common is hemorrhagic stroke on initial head CT scan and how often is initial clinical diagnosis of acute stroke eventually confirmed? Am J Neuroradiol 2005;26:2207-2212.
Stroke Unit Trialists’ Collaboration. Organized inpatient (stroke unit) care for stroke. Cochrane DB Syst Rev 2009:CD000197.
Passero S, Rocchi R, Rossi S, et al. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002;43:1175-1180.
Pexman JH, Barber PA, Hill MD, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. Am J Neuroradiol 2001;22:1534-1542.
Program early CT score (ASPECTS) for assessing CT scans in patients with acute strokes. AMJ Neuroradiol 2001;22:1534-1542.
Robertson L, Kesteven P, McCaslin JE. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. Cochrane DB Syst Rev. 2015;6:CD010956.
Rodrigues FB, Neves JB, Caldeira D, et al. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ 2016;353:i1754.
The ESPRIT Study Group. Aspirin® plus dipyridamole versus Aspirin® alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial. Lancet 2006;367:1665-1673.
The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an ACEI, ramipril, on cardiovascular events in high-risk patients. NEJM 2000;342:145-153.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. NEJM 1995;333:1581-1588.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Effects of tissue plasminogen activator for acute ischemic stroke at one year. NEJM 1999;340:1781-1787.
Traumatic Brain Injury
Anderson-Barnes VC, Weeks SR, Tsao JW. Mild traumatic brain injury update. Continuum 2010;16(6):17-23.